Thymus staging
(Redirected from Masaoka)
Jump to navigation
Jump to search
This article deals with thymus staging. An introduction to staging is in the cancer staging systems article.
Thymic staging, thymus cancer staging, thymic carcinoma staging, Masaoka-Koga classification, and thymus tumour staging redirect here.
Overview
There is a system by Masaoka and colleagues[1] that was subsequently modified, and is known as the modified Masaoka staging system.[2]
Based on CAP protocol
Staging as per Butnor et al.:[3]
| Stage | Characteristics |
|---|---|
| I | encapsulated lesion, tumour does not penetrate capsule |
| IIa | microscopic penetration of the capsule |
| IIb | macroscopic penetration of the capsule |
| III | macroscopic invasion of adjacent organs |
| IVa | pleural or pericardial spread |
| IVb | lymphatic or hematogenous spread ‡ |
Note:
- ‡ The International Thymic Malignancy Interest Group (ITMIG) notes that is must have spread to distant organs.[4] This implies that lymphovascular invasion within the tumour itself is not sufficient for calling stage IVb.
Modified Masaoka as per Masaoka et al. (1999)
T-stage - based on Masaoka et al. (1999):[5]
| Stage | Features |
|---|---|
| T1 | macroscopically and microscopically encapulated |
| T2 | macroscopic invasion or adhesion to surrounding tissue (fat or pleura) or microscopic invasion into the capsule |
| T3 | Spread to adjacent organs, e.g. pericardium, lung, great vessels. |
| T4 | pericardial or pleural spread |
N-stage - based on Masaoka et al. (1999):[5]
| Stage | Features |
|---|---|
| N0 | no lymph node spread |
| N1 | spread to anterior mediastinal lymph nodes |
| N2 | spread to intrathoracic lymph nodes other than the mediastinal lymph nodes |
| N3 | spread to supraclavicular lymph nodes |
M-stage - based on Masaoka et al. (1999):[5]
| Stage | Features |
|---|---|
| M0 | no hematogeneous spread and extrathoracic lymph nodes with the exception of the supraclavicular nodes |
| M1 | hematogeneous spread and/or extrathoracic lymph nodes |
See also
References
- ↑ Masaoka, A.; Monden, Y.; Nakahara, K.; Tanioka, T. (Dec 1981). "Follow-up study of thymomas with special reference to their clinical stages.". Cancer 48 (11): 2485-92. PMID 7296496.
- ↑ Koga, K.; Matsuno, Y.; Noguchi, M.; Mukai, K.; Asamura, H.; Goya, T.; Shimosato, Y. (May 1994). "A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma.". Pathol Int 44 (5): 359-67. PMID 8044305.
- ↑ Butnor KJ et al. Thymus. Version 3.1.0.0. 2011. URL: www.cap.org/cancerprotocols. Accessed on: 31 August 2015.
- ↑ URL: https://www.itmig.org/node/9. Accessed on: May 13, 2016.
- ↑ 5.0 5.1 5.2 Masaoka, A.; Yamakawa, Y.; Fujii, Y. (Mar 1999). "Well-differentiated thymic carcinoma: is it thymic carcinoma or not?". J Thorac Cardiovasc Surg 117 (3): 628-30. PMID 10047676.